ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2310건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2121 | Unknown status | A Study to Evaluate Safety & Immunogenicity of SARS-CoV-2 DNA Vaccine Delivered Intramuscularly Followed by Electroporation for COVID-19 | Covid19 | Biological: SARS-CoV-2 DNA Vaccine Biological: Matching placebo |
Phase 1 | The University of Hong Kong, Immuno Cure 3 Limited | OTHER | 30 | All | 18 Years ~ 55 Years | HKU Phase 1 Clinical Trials Centre, Hong Kong, Hong Kong |
| 2120 | Completed | A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19) | COVID-19 | Biological: Convalescent anti-SARS-CoV-2 MBT Plasma Drug: Standard Medical Treatment |
Phase 2 | Instituto Grifols, S.A. | INDUSTRY | 200 | All | 18 Years | Hospital General Universitario de Alicante, Alicante, Spain Hospital Universitari Vall d'Hebron, Barcelona, Spain Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Fundacion Jimenez Diaz, Madrid, Spain Hospital Clinico San Carlos, Madrid, Spain Hospital Universitario La Paz, Madrid, Spain Hospital Universitario La Princesa, Madrid, Spain Complejo Hospitalario Universitario de Canarias, Santa Cruz De Tenerife, Spain Hospital Clinico Universitario de Santiago -CHUS, Santiago, Spain Hospital Universitari Joan XXIII, Tarragona, Spain |
| 2119 | Completed | A Study to Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19) | SARS-CoV-2 Infection | Biological: NVX-CoV2373 | Phase 2 | Novavax | INDUSTRY | 384 | All | 18 Years ~ 65 Years | KwaPhila Health Solutions (Enhancing Care), Westridge, Durban, South Africa Josha Research, Bloemfontein, Free State, South Africa The Aurum Institute Pretoria Clinical Research Services, Pretoria, Gauteng, South Africa Wits Vaccines & Infectious Diseases Analytics (VIDA) Research Unit, Diepkloof, Johannesburg, South Africa Wits RHI Shandukani Research Centre, Hillbrow, Johannesburg, South Africa MERC Research (Pty) Ltd - Middelburg, Middelburg, Mpumalanga, South Africa Madibeng Centre for Research, Brits, North-West, South Africa |
| 2118 | Unknown status | A Study to Evaluate Safety and Immunogenicity of DelNS1-nCoV-RBD LAIV for COVID-19 | Covid19 | Biological: DelNS1-nCoV-RBD LAIV Biological: Matching placebo |
Phase 1 | The University of Hong Kong | OTHER | 115 | All | 18 Years ~ 55 Years | HKU Phase 1 Clinical Trials Centre, Hong Kong, Hong Kong |
| 2117 | Completed | A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults | COVID-19 | Biological: BNT162b2 | Phase 3 | BioNTech SE, Pfizer | INDUSTRY | 629 | All | 18 Years ~ 55 Years | Anaheim Clinical Trials, LLC, Anaheim, California, United States Diablo Clinical Research, Inc., Walnut Creek, California, United States Indago Research & Health Center, Inc, Hialeah, Florida, United States Research Centers of America ( Hollywood ), Hollywood, Florida, United States Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Jacksonville, Florida, United States Clinical Neuroscience Solutions, Orlando, Florida, United States Clinical Research Atlanta, Stockbridge, Georgia, United States East-West Medical Research Institute, Honolulu, Hawaii, United States Solaris Clinical Research, Meridian, Idaho, United States Kentucky Pediatric/ Adult Research, Bardstown, Kentucky, United States Meridian Clinical Research, LLC, Omaha, Nebraska, United States Amici Clinical Research LLC, Raritan, New Jersey, United States Accellacare (formerly PMG Research of Wilmington, LLC), Wilmington, North Carolina, United States Aventiv Research Inc, Columbus, Ohio, United States Benchmark Research, Austin, Texas, United States University of Texas Medical Branch, Galveston, Texas, United States Texas Center for Drug Development, Inc., Houston, Texas, United States DM Clinical Research (Administrative and Storage Office only), Tomball, Texas, United States Martin Diagnostic Clinic, Tomball, Texas, United States J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City, Utah, United States J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City, Utah, United States |
| 2116 | Active, not recruiting | A Study to Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines | COVID-19 | Biological: ABO1009-DP Biological: ABO-CoV.617.2 Other: Placebo |
Phase 1 | Suzhou Abogen Biosciences Co., Ltd. | INDUSTRY | 60 | All | 18 Years | Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia Persahabatan Hospital, Jakarta, Indonesia |
| 2115 | Withdrawn | A Study to Evaluate the Ability of UB-612 COVID-19 Vaccine to Boost Immunity of Heterologous COVID-19 Vaccines. | COVID-19 | Biological: UB-612 | Phase 1 | United Biomedical Inc., Asia | INDUSTRY | 0 | All | 20 Years ~ 55 Years |
